These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
3. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Correll CU; Frederickson AM; Kane JM; Manu P Bipolar Disord; 2008 Nov; 10(7):788-97. PubMed ID: 19032710 [TBL] [Abstract][Full Text] [Related]
4. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs. Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442 [TBL] [Abstract][Full Text] [Related]
8. Implementation of monitoring and management guidelines for second-generation antipsychotics. Sernyak MJ J Clin Psychiatry; 2007; 68 Suppl 4():14-8. PubMed ID: 17539695 [TBL] [Abstract][Full Text] [Related]
9. Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization. Masand PS; Culpepper L; Henderson D; Lee S; Littrell K; Newcomer JW; Rasgon N CNS Spectr; 2005 Oct; 10(10):suppl14 1-15. PubMed ID: 16404802 [TBL] [Abstract][Full Text] [Related]
10. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study. Bai YM; Chen TT; Yang WS; Chi YC; Lin CC; Liou YJ; Wang YC; Su TP; Chou P; Chen JY Schizophr Res; 2009 Jun; 111(1-3):1-8. PubMed ID: 19409756 [TBL] [Abstract][Full Text] [Related]
11. A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients. Mackin P; Bishop DR; Watkinson HM BMC Psychiatry; 2007 Jun; 7():28. PubMed ID: 17592636 [TBL] [Abstract][Full Text] [Related]
12. Factors in second-generation antipsychotic switching patterns in a national sample of older veterans with schizophrenia. Dassori AM; Copeland LA; Zeber JE; Miller AL Psychiatr Serv; 2011 Jan; 62(1):47-53. PubMed ID: 21209299 [TBL] [Abstract][Full Text] [Related]
16. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review. De Hert M; Schreurs V; Sweers K; Van Eyck D; Hanssens L; Sinko S; Wampers M; Scheen A; Peuskens J; van Winkel R Schizophr Res; 2008 Apr; 101(1-3):295-303. PubMed ID: 18299188 [TBL] [Abstract][Full Text] [Related]
17. [Metabolic side effects of risperidone in early onset schizophrenia]. Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267 [TBL] [Abstract][Full Text] [Related]
18. [Metabolic risk during antipsychotic treatment in patients with schizophrenia]. Rzewuska M Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977 [TBL] [Abstract][Full Text] [Related]
19. Long-term metabolic and cardiovascular effects of antipsychotic drugs. A meta-analysis of randomized controlled trials. Rotella F; Cassioli E; Calderani E; Lazzeretti L; Ragghianti B; Ricca V; Mannucci E Eur Neuropsychopharmacol; 2020 Mar; 32():56-65. PubMed ID: 31917068 [TBL] [Abstract][Full Text] [Related]